NGM BIOPHARMACEUTICALS INC Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
NGM BIOPHARMACEUTICALS INC reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of -$16.96 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2024-03-11
- NGM BIOPHARMACEUTICALS INC increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2023-12-31 was $936.00K, a 86.08% increase year-over-year.
- NGM BIOPHARMACEUTICALS INC increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2023-09-30 was -$2.99M, a 134.53% decline year-over-year.
- NGM BIOPHARMACEUTICALS INC increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2023-06-30 was -$1.49M.
- NGM BIOPHARMACEUTICALS INC increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2023-03-31 was -$13.42M.
- NGM BIOPHARMACEUTICALS INC increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2023 was -$16.96M.
- NGM BIOPHARMACEUTICALS INC increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2022 was -$589.00K, a 120.36% decline from fiscal 2021.
- NGM BIOPHARMACEUTICALS INC increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2021 was $2.89M, a 53.20% decline from fiscal 2020.
- NGM BIOPHARMACEUTICALS INC increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2020 was $6.18M, a 30.36% decline from fiscal 2019.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2023-12-31 | $936.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | -$2.05M derived: sum of 2 quarters · filed 2024-03-11 | -$3.54M derived: sum of 3 quarters · filed 2024-03-11 | -$16.96M 10-K · filed 2024-03-11 |
| 2023-09-30 | -$2.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$4.48M derived: sum of 2 quarters · filed 2023-11-02 | -$17.90M 10-Q · filed 2023-11-02 | -$17.40M derived: sum of 4 quarters · filed 2024-03-11 |
| 2023-06-30 | -$1.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$14.91M 10-Q · filed 2023-08-03 | -$14.41M derived: sum of 3 quarters · filed 2024-03-11 | -$5.76M derived: sum of 4 quarters · filed 2024-03-11 |
| 2023-03-31 | -$13.42M 10-Q · filed 2023-05-04 | -$12.92M derived: sum of 2 quarters · filed 2024-03-11 | -$4.27M derived: sum of 3 quarters · filed 2024-03-11 | -$9.27M derived: sum of 4 quarters · filed 2024-03-11 |
| 2022-12-31 | $503.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $9.15M derived: sum of 2 quarters · filed 2024-03-11 | $4.16M derived: sum of 3 quarters · filed 2024-03-11 | -$589.00K 10-K · filed 2024-03-11 |
| 2022-09-30 | $8.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $3.65M derived: sum of 2 quarters · filed 2023-11-02 | -$1.09M 10-Q · filed 2023-11-02 | -$3.13M derived: sum of 4 quarters · filed 2024-03-11 |
| 2022-06-30 | -$4.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$9.74M 10-Q · filed 2023-08-03 | -$11.78M derived: sum of 3 quarters · filed 2024-03-11 | -$8.88M derived: sum of 4 quarters · filed 2024-03-11 |
| 2022-03-31 | -$4.75M 10-Q · filed 2023-05-04 | -$6.79M derived: sum of 2 quarters · filed 2024-03-11 | -$3.89M derived: sum of 3 quarters · filed 2024-03-11 | -$1.43M derived: sum of 4 quarters · filed 2024-03-11 |
| 2021-12-31 | -$2.04M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $855.00K derived: sum of 2 quarters · filed 2024-03-11 | $3.32M derived: sum of 3 quarters · filed 2024-03-11 | $2.89M 10-K · filed 2024-03-11 |
| 2021-09-30 | $2.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $5.36M derived: sum of 2 quarters · filed 2022-11-03 | $4.93M 10-Q · filed 2022-11-03 | $1.35M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $2.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $2.04M 10-Q · filed 2022-08-04 | -$1.54M derived: sum of 3 quarters · filed 2023-02-28 | $586.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$427.00K 10-Q · filed 2022-05-05 | -$4.01M derived: sum of 2 quarters · filed 2023-02-28 | -$1.88M derived: sum of 3 quarters · filed 2023-02-28 | $2.73M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | -$3.58M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$1.45M derived: sum of 2 quarters · filed 2023-02-28 | $3.16M derived: sum of 3 quarters · filed 2023-02-28 | $6.18M 10-K · filed 2023-02-28 |
| 2020-09-30 | $2.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $6.74M derived: sum of 2 quarters · filed 2021-11-04 | $9.77M 10-Q · filed 2021-11-04 | $14.16M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $4.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $7.63M 10-Q · filed 2021-08-05 | $12.03M derived: sum of 3 quarters · filed 2022-03-01 | $15.34M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $3.03M 10-Q · filed 2021-05-06 | $7.42M derived: sum of 2 quarters · filed 2022-03-01 | $10.74M derived: sum of 3 quarters · filed 2022-03-01 | $13.09M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $4.39M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $7.71M derived: sum of 2 quarters · filed 2022-03-01 | $10.06M derived: sum of 3 quarters · filed 2022-03-01 | $8.88M 10-K · filed 2022-03-01 |
| 2019-09-30 | $3.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $5.67M derived: sum of 2 quarters · filed 2020-11-12 | $4.49M 10-Q · filed 2020-11-12 | $8.00M derived: sum of 4 quarters · filed 2021-03-15 |
| 2019-06-30 | $2.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $1.17M 10-Q · filed 2020-08-12 | $4.68M derived: sum of 3 quarters · filed 2021-03-15 | $5.64M derived: sum of 4 quarters · filed 2021-03-15 |
| 2019-03-31 | -$1.18M 10-Q · filed 2020-05-13 | $2.33M derived: sum of 2 quarters · filed 2021-03-15 | $3.29M derived: sum of 3 quarters · filed 2021-03-15 | $6.25M derived: sum of 4 quarters · filed 2021-03-15 |
| 2018-12-31 | $3.51M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $4.47M derived: sum of 2 quarters · filed 2021-03-15 | $7.43M derived: sum of 3 quarters · filed 2021-03-15 | $4.06M 10-K · filed 2021-03-15 |
| 2018-09-30 | $964.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $3.92M derived: sum of 2 quarters · filed 2019-11-12 | $549.00K 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $2.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | -$415.00K 10-Q · filed 2019-08-12 | ||
| 2018-03-31 | -$3.37M 10-Q · filed 2019-05-16 | |||
| 2017-12-31 | $2.60M 10-K · filed 2020-03-17 |